rs7023474

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002451.4(MTAP):​c.121-67A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.556 in 1,408,308 control chromosomes in the GnomAD database, including 223,780 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.63 ( 31459 hom., cov: 32)
Exomes 𝑓: 0.55 ( 192321 hom. )

Consequence

MTAP
NM_002451.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.622

Publications

6 publications found
Variant links:
Genes affected
MTAP (HGNC:7413): (methylthioadenosine phosphorylase) This gene encodes an enzyme that plays a major role in polyamine metabolism and is important for the salvage pathway of both adenine and methionine. The encoded enzyme is deficient in many cancers. Multiple alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Sep 2021]
MTAP Gene-Disease associations (from GenCC):
  • diaphyseal medullary stenosis-bone malignancy syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Genomics England PanelApp, G2P, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 9-21816647-A-G is Benign according to our data. Variant chr9-21816647-A-G is described in ClinVar as [Benign]. Clinvar id is 1239449.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.809 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTAPNM_002451.4 linkc.121-67A>G intron_variant Intron 2 of 7 ENST00000644715.2 NP_002442.2 Q13126-1A0A384ME80

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTAPENST00000644715.2 linkc.121-67A>G intron_variant Intron 2 of 7 NM_002451.4 ENSP00000494373.1 Q13126-1

Frequencies

GnomAD3 genomes
AF:
0.632
AC:
96005
AN:
151874
Hom.:
31401
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.816
Gnomad AMI
AF:
0.567
Gnomad AMR
AF:
0.628
Gnomad ASJ
AF:
0.581
Gnomad EAS
AF:
0.708
Gnomad SAS
AF:
0.414
Gnomad FIN
AF:
0.543
Gnomad MID
AF:
0.576
Gnomad NFE
AF:
0.549
Gnomad OTH
AF:
0.603
GnomAD4 exome
AF:
0.547
AC:
687281
AN:
1256316
Hom.:
192321
AF XY:
0.540
AC XY:
342013
AN XY:
632976
show subpopulations
African (AFR)
AF:
0.821
AC:
23725
AN:
28912
American (AMR)
AF:
0.665
AC:
26406
AN:
39728
Ashkenazi Jewish (ASJ)
AF:
0.571
AC:
13639
AN:
23886
East Asian (EAS)
AF:
0.636
AC:
24254
AN:
38150
South Asian (SAS)
AF:
0.405
AC:
31281
AN:
77154
European-Finnish (FIN)
AF:
0.560
AC:
27080
AN:
48350
Middle Eastern (MID)
AF:
0.527
AC:
2770
AN:
5258
European-Non Finnish (NFE)
AF:
0.540
AC:
508018
AN:
941520
Other (OTH)
AF:
0.564
AC:
30108
AN:
53358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
13602
27203
40805
54406
68008
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13716
27432
41148
54864
68580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.632
AC:
96126
AN:
151992
Hom.:
31459
Cov.:
32
AF XY:
0.627
AC XY:
46581
AN XY:
74272
show subpopulations
African (AFR)
AF:
0.816
AC:
33853
AN:
41490
American (AMR)
AF:
0.628
AC:
9598
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.581
AC:
2016
AN:
3472
East Asian (EAS)
AF:
0.708
AC:
3658
AN:
5164
South Asian (SAS)
AF:
0.416
AC:
1999
AN:
4810
European-Finnish (FIN)
AF:
0.543
AC:
5724
AN:
10538
Middle Eastern (MID)
AF:
0.588
AC:
173
AN:
294
European-Non Finnish (NFE)
AF:
0.549
AC:
37314
AN:
67928
Other (OTH)
AF:
0.604
AC:
1275
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1744
3487
5231
6974
8718
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
756
1512
2268
3024
3780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.583
Hom.:
4705
Bravo
AF:
0.655
Asia WGS
AF:
0.581
AC:
2020
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
6.3
DANN
Benign
0.77
PhyloP100
0.62
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7023474; hg19: chr9-21816646; COSMIC: COSV66477127; COSMIC: COSV66477127; API